Tehran-SANA
The Iranian Pasteur Institute announced that it has received 100,000 doses of the Cuban Corona vaccine for use in clinical testing in Iran.
Fars News Agency quoted the "Pew Copa Pharma" Foundation as saying that the third phase of testing the "Sabrana" vaccine will be completed with the arrival of 100,000 doses of the vaccine to Iran.
At the beginning of this year, the Cuban Foundation concluded an agreement with the Iranian Pasteur Institute to test the third and final clinical phase in Iran.